Perspective Therapeutics (FRA:AAJ) Additional Paid-In Capital : €362.51 Mil(As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Additional Paid-In Capital?

Perspective Therapeutics's quarterly additional paid-in capital declined from Sep. 2023 (€212.00 Mil) to Dec. 2023 (€208.47 Mil) but then increased from Dec. 2023 (€208.47 Mil) to Mar. 2024 (€362.51 Mil).

Perspective Therapeutics's annual additional paid-in capital increased from Jun. 2021 (€131.63 Mil) to Jun. 2022 (€151.11 Mil) and increased from Jun. 2022 (€151.11 Mil) to Dec. 2023 (€208.47 Mil).

Perspective Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Perspective Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Additional Paid-In Capital Chart

Perspective Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

81.51

83.11

131.63

151.11

208.47

Perspective Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															209.27	208.40	212.00	208.47	362.51

Perspective Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Perspective Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics (FRA:AAJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ:Germany

Address

350 Hills Street, Suite 106, Richland, WA, USA, 99354

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines